Salvato in:
Dettagli Bibliografici
Autori principali: Jiménez-López, M. Carmen, Moreno-Maldonado, Ana Carolina, Martín-Morales, Natividad, OValle, Francisco, Ibarra, M. Ricardo, Goya, Gerardo F., Molina, Ignacio J.
Natura: Preprint
Pubblicazione: 2024
Soggetti:
Accesso online:https://arxiv.org/abs/2411.15167
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
_version_ 1866915031327703040
author Jiménez-López, M. Carmen
Moreno-Maldonado, Ana Carolina
Martín-Morales, Natividad
OValle, Francisco
Ibarra, M. Ricardo
Goya, Gerardo F.
Molina, Ignacio J.
author_facet Jiménez-López, M. Carmen
Moreno-Maldonado, Ana Carolina
Martín-Morales, Natividad
OValle, Francisco
Ibarra, M. Ricardo
Goya, Gerardo F.
Molina, Ignacio J.
contents There are several methods to improve cancer patient survival rates by inducing hyperthermia in tumor tissues, which involves raising their temperature above 41°C. These methods utilize different energy sources to deliver heat to the target region, including light, microwaves or radiofrequency electromagnetic fields. We have developed a new, magnetically responsive nanocarrier, consisting of liposomes loaded with magnetic nanoparticles and cis-diamminedichloroplatinum (II) (CDDP), commonly known as Cisplatin. The resulting magnetoliposome (ML) is rapidly internalized by lung and pancreas tumor cell lines, stored in intracellular vesicles, and capable of inducing hyperthermia under magnetic fields. The ML has no significant toxicity both in vitro and in vivo and, most importantly, enhances cell death by apoptosis after magnetic hyperthermia. Remarkably, mice bearing induced lung tumors, treated with CDDP-loaded nanocarriers and subjected to an applied electromagnetic field, showed an improved survival rate over those treated with either soluble CDDP or hyperthermia alone. Therefore, our approach of magnetic hyperthermia plus CDDP-ML significantly enhances in vitro cell death and in vivo survival of treated animals.
format Preprint
id arxiv_https___arxiv_org_abs_2411_15167
institution arXiv
publishDate 2024
record_format arxiv
spellingShingle Novel Cisplatin-Magnetoliposome Complex Shows Enhanced Antitumor Activity via Hyperthermia
Jiménez-López, M. Carmen
Moreno-Maldonado, Ana Carolina
Martín-Morales, Natividad
OValle, Francisco
Ibarra, M. Ricardo
Goya, Gerardo F.
Molina, Ignacio J.
Tissues and Organs
Soft Condensed Matter
There are several methods to improve cancer patient survival rates by inducing hyperthermia in tumor tissues, which involves raising their temperature above 41°C. These methods utilize different energy sources to deliver heat to the target region, including light, microwaves or radiofrequency electromagnetic fields. We have developed a new, magnetically responsive nanocarrier, consisting of liposomes loaded with magnetic nanoparticles and cis-diamminedichloroplatinum (II) (CDDP), commonly known as Cisplatin. The resulting magnetoliposome (ML) is rapidly internalized by lung and pancreas tumor cell lines, stored in intracellular vesicles, and capable of inducing hyperthermia under magnetic fields. The ML has no significant toxicity both in vitro and in vivo and, most importantly, enhances cell death by apoptosis after magnetic hyperthermia. Remarkably, mice bearing induced lung tumors, treated with CDDP-loaded nanocarriers and subjected to an applied electromagnetic field, showed an improved survival rate over those treated with either soluble CDDP or hyperthermia alone. Therefore, our approach of magnetic hyperthermia plus CDDP-ML significantly enhances in vitro cell death and in vivo survival of treated animals.
title Novel Cisplatin-Magnetoliposome Complex Shows Enhanced Antitumor Activity via Hyperthermia
topic Tissues and Organs
Soft Condensed Matter
url https://arxiv.org/abs/2411.15167